Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 4 May 2020. Liz Richardson.

Executive Summary

Pew Charitable Trusts urged the Biden administration to undo Trump-era changes to regulation of laboratory developed tests (LDTs) and hand their control to the US Food and Drug Administration in a letter signed by Liz Richardson , the group’s project director for health care products.

“The current crisis has further highlighted the urgent need for a uniform, commonly understood regulatory framework for all in vitro clinical tests and one that appropriately balances the need for rapid innovation with the need to ensure test quality.” – Liz Richardson, Project Director, Health Care Products, Pew Charitable Trusts

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts